Concourse Financial Group Securities, Inc. Oncolytics Biotech Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.87 - $1.08 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.99 - $1.24 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.89 - $1.36 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.22 - $2.09 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.98 - $3.24 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.98 - $3.24 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.11 - $2.74 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.2 - $1.91 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.17 - $2.12 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.98 - $1.51 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.85 - $1.59 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.31 - $2.02 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$1.39 - $2.3 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$1.93 - $2.77 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$2.6 - $4.64 $0 - $0
Q1 2021 May 13, 2021	BUY	$2.32 - $4.11 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$1.71 - $4.03 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$1.58 - $2.15 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$1.33 - $2.76 $0 - $0
Q1 2020 May 13, 2020	BUY	$0.98 - $4.28 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$0.42 - $4.76 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$0.54 - $1.71 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$1.63 - $1.95 $0 - $0
Q1 2019 May 15, 2019	BUY	$1.77 - $2.31 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$1.72 - $4.12 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$3.83 - $5.92 $0 - $0

Others Institutions Holding ONCY

# of Institutions

Shares Held

1.18M

Call Options Held

Put Options Held

Seeds Investor LLC New York, NY

190K
Shares

$176,645
0.06% of portfolio
International Assets Investment Management, LLC Orlando, FL

174K
Shares

$162,127
0.55% of portfolio
Goldman Sachs Group Inc New York, NY

85K
Shares

$79,048
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

79.2K
Shares

$73,701
0.0% of portfolio
Royal Bank Of Canada Toronto, A6

74.5K
Shares

$69,327
0.0% of portfolio

View Full List

About ONCOLYTICS BIOTECH INC

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $53.8M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

More about ONCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account